Tolerance Bio focuses on using cell implantation therapy to treat DiGeorge syndrome, a genetic condition causing thymus absence or underdevelopment. This impacts the immune system, leading to infections and potential heart issues in affected children. DiGeorge syndrome, also known as 22q11.2 deletion syndrome, presents significant challenges in medical management due to its complex nature and varied symptoms, necessitating innovative approaches such as cell therapy to address the underlying genetic cause.
Read more from technical.ly
